FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:212 January 21, 1993 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: Takemoto et al. (Sept. 17 issue)¹ report a 9 percent improvement in one-year graft survival and a doubling of the estimated half-life for cadaveric renal allografts matched for six antigens, as compared with HLA-mismatched allografts. However, in their analysis of risk factors for graft failure, the effect of using ABO-compatible but mismatched grafts (organs from donors with type O blood were used in recipients with type A, B, or AB blood; organs from donors with type A or B blood were used in recipients with type AB blood) was not studied. The possible adverse effects of using . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.